BRAF and neoplasm: All these results are in accordance with the principles of molecular and biomarker analysis for BRAF by NCCN guideline: “Real-time PCR, Sanger sequencing (ideally paired with tumor enrichment), and NGS are the most commonly deployed methodologies for examining BRAF mutation status” (NCCN Guidelines Version 3.2023).